Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
CAR T-Cell Therapy market report explains the definition, types, applications, major countries, and major players of the CAR T-Cell Therapy market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
CARsgen Therapeutics (China)
Sorrento Therapeutics (US)
Kite Pharma (US)
Legend Biotech (US)
Pfizer, Inc (US)
Mustang Bio (US)
Juno Therapeutics (US)
Novartis AG (Switzerland)
Cellectis (France)
Autolus Therapeutics PLC (UK)
By Type:
Allogeneic
Autologous
By End-User:
Hospitals
Cancer Research Centers
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global CAR T-Cell Therapy Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 CAR T-Cell Therapy Outlook to 2028- Original Forecasts
-
2.2 CAR T-Cell Therapy Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term CAR T-Cell Therapy Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global CAR T-Cell Therapy Market- Recent Developments
-
6.1 CAR T-Cell Therapy Market News and Developments
-
6.2 CAR T-Cell Therapy Market Deals Landscape
7 CAR T-Cell Therapy Raw Materials and Cost Structure Analysis
-
7.1 CAR T-Cell Therapy Key Raw Materials
-
7.2 CAR T-Cell Therapy Price Trend of Key Raw Materials
-
7.3 CAR T-Cell Therapy Key Suppliers of Raw Materials
-
7.4 CAR T-Cell Therapy Market Concentration Rate of Raw Materials
-
7.5 CAR T-Cell Therapy Cost Structure Analysis
-
7.5.1 CAR T-Cell Therapy Raw Materials Analysis
-
7.5.2 CAR T-Cell Therapy Labor Cost Analysis
-
7.5.3 CAR T-Cell Therapy Manufacturing Expenses Analysis
8 Global CAR T-Cell Therapy Import and Export Analysis (Top 10 Countries)
-
8.1 Global CAR T-Cell Therapy Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global CAR T-Cell Therapy Export by Region (Top 10 Countries) (2017-2028)
9 Global CAR T-Cell Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global CAR T-Cell Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Allogeneic Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Autologous Consumption and Growth Rate (2017-2022)
-
9.2 Global CAR T-Cell Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Research Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise CAR T-Cell Therapy Market Analysis and Outlook till 2022
-
10.1 Global CAR T-Cell Therapy Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States CAR T-Cell Therapy Consumption (2017-2022)
-
10.2.2 Canada CAR T-Cell Therapy Consumption (2017-2022)
-
10.2.3 Mexico CAR T-Cell Therapy Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany CAR T-Cell Therapy Consumption (2017-2022)
-
10.3.2 UK CAR T-Cell Therapy Consumption (2017-2022)
-
10.3.3 Spain CAR T-Cell Therapy Consumption (2017-2022)
-
10.3.4 Belgium CAR T-Cell Therapy Consumption (2017-2022)
-
10.3.5 France CAR T-Cell Therapy Consumption (2017-2022)
-
10.3.6 Italy CAR T-Cell Therapy Consumption (2017-2022)
-
10.3.7 Denmark CAR T-Cell Therapy Consumption (2017-2022)
-
10.3.8 Finland CAR T-Cell Therapy Consumption (2017-2022)
-
10.3.9 Norway CAR T-Cell Therapy Consumption (2017-2022)
-
10.3.10 Sweden CAR T-Cell Therapy Consumption (2017-2022)
-
10.3.11 Poland CAR T-Cell Therapy Consumption (2017-2022)
-
10.3.12 Russia CAR T-Cell Therapy Consumption (2017-2022)
-
10.3.13 Turkey CAR T-Cell Therapy Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China CAR T-Cell Therapy Consumption (2017-2022)
-
10.4.2 Japan CAR T-Cell Therapy Consumption (2017-2022)
-
10.4.3 India CAR T-Cell Therapy Consumption (2017-2022)
-
10.4.4 South Korea CAR T-Cell Therapy Consumption (2017-2022)
-
10.4.5 Pakistan CAR T-Cell Therapy Consumption (2017-2022)
-
10.4.6 Bangladesh CAR T-Cell Therapy Consumption (2017-2022)
-
10.4.7 Indonesia CAR T-Cell Therapy Consumption (2017-2022)
-
10.4.8 Thailand CAR T-Cell Therapy Consumption (2017-2022)
-
10.4.9 Singapore CAR T-Cell Therapy Consumption (2017-2022)
-
10.4.10 Malaysia CAR T-Cell Therapy Consumption (2017-2022)
-
10.4.11 Philippines CAR T-Cell Therapy Consumption (2017-2022)
-
10.4.12 Vietnam CAR T-Cell Therapy Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil CAR T-Cell Therapy Consumption (2017-2022)
-
10.5.2 Colombia CAR T-Cell Therapy Consumption (2017-2022)
-
10.5.3 Chile CAR T-Cell Therapy Consumption (2017-2022)
-
10.5.4 Argentina CAR T-Cell Therapy Consumption (2017-2022)
-
10.5.5 Venezuela CAR T-Cell Therapy Consumption (2017-2022)
-
10.5.6 Peru CAR T-Cell Therapy Consumption (2017-2022)
-
10.5.7 Puerto Rico CAR T-Cell Therapy Consumption (2017-2022)
-
10.5.8 Ecuador CAR T-Cell Therapy Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain CAR T-Cell Therapy Consumption (2017-2022)
-
10.6.2 Kuwait CAR T-Cell Therapy Consumption (2017-2022)
-
10.6.3 Oman CAR T-Cell Therapy Consumption (2017-2022)
-
10.6.4 Qatar CAR T-Cell Therapy Consumption (2017-2022)
-
10.6.5 Saudi Arabia CAR T-Cell Therapy Consumption (2017-2022)
-
10.6.6 United Arab Emirates CAR T-Cell Therapy Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria CAR T-Cell Therapy Consumption (2017-2022)
-
10.7.2 South Africa CAR T-Cell Therapy Consumption (2017-2022)
-
10.7.3 Egypt CAR T-Cell Therapy Consumption (2017-2022)
-
10.7.4 Algeria CAR T-Cell Therapy Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia CAR T-Cell Therapy Consumption (2017-2022)
-
10.8.2 New Zealand CAR T-Cell Therapy Consumption (2017-2022)
11 Global CAR T-Cell Therapy Competitive Analysis
-
11.1 CARsgen Therapeutics (China)
-
11.1.1 CARsgen Therapeutics (China) Company Details
-
11.1.2 CARsgen Therapeutics (China) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 CARsgen Therapeutics (China) CAR T-Cell Therapy Main Business and Markets Served
-
11.1.4 CARsgen Therapeutics (China) CAR T-Cell Therapy Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Sorrento Therapeutics (US)
-
11.2.1 Sorrento Therapeutics (US) Company Details
-
11.2.2 Sorrento Therapeutics (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Sorrento Therapeutics (US) CAR T-Cell Therapy Main Business and Markets Served
-
11.2.4 Sorrento Therapeutics (US) CAR T-Cell Therapy Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Kite Pharma (US)
-
11.3.1 Kite Pharma (US) Company Details
-
11.3.2 Kite Pharma (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Kite Pharma (US) CAR T-Cell Therapy Main Business and Markets Served
-
11.3.4 Kite Pharma (US) CAR T-Cell Therapy Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Legend Biotech (US)
-
11.4.1 Legend Biotech (US) Company Details
-
11.4.2 Legend Biotech (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Legend Biotech (US) CAR T-Cell Therapy Main Business and Markets Served
-
11.4.4 Legend Biotech (US) CAR T-Cell Therapy Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Pfizer, Inc (US)
-
11.5.1 Pfizer, Inc (US) Company Details
-
11.5.2 Pfizer, Inc (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Pfizer, Inc (US) CAR T-Cell Therapy Main Business and Markets Served
-
11.5.4 Pfizer, Inc (US) CAR T-Cell Therapy Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Mustang Bio (US)
-
11.6.1 Mustang Bio (US) Company Details
-
11.6.2 Mustang Bio (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Mustang Bio (US) CAR T-Cell Therapy Main Business and Markets Served
-
11.6.4 Mustang Bio (US) CAR T-Cell Therapy Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Juno Therapeutics (US)
-
11.7.1 Juno Therapeutics (US) Company Details
-
11.7.2 Juno Therapeutics (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Juno Therapeutics (US) CAR T-Cell Therapy Main Business and Markets Served
-
11.7.4 Juno Therapeutics (US) CAR T-Cell Therapy Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Novartis AG (Switzerland)
-
11.8.1 Novartis AG (Switzerland) Company Details
-
11.8.2 Novartis AG (Switzerland) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Novartis AG (Switzerland) CAR T-Cell Therapy Main Business and Markets Served
-
11.8.4 Novartis AG (Switzerland) CAR T-Cell Therapy Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Cellectis (France)
-
11.9.1 Cellectis (France) Company Details
-
11.9.2 Cellectis (France) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Cellectis (France) CAR T-Cell Therapy Main Business and Markets Served
-
11.9.4 Cellectis (France) CAR T-Cell Therapy Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Autolus Therapeutics PLC (UK)
-
11.10.1 Autolus Therapeutics PLC (UK) Company Details
-
11.10.2 Autolus Therapeutics PLC (UK) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Autolus Therapeutics PLC (UK) CAR T-Cell Therapy Main Business and Markets Served
-
11.10.4 Autolus Therapeutics PLC (UK) CAR T-Cell Therapy Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global CAR T-Cell Therapy Market Outlook by Types and Applications to 2028
-
12.1 Global CAR T-Cell Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Allogeneic Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Autologous Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global CAR T-Cell Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Cancer Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise CAR T-Cell Therapy Market Analysis and Outlook to 2028
-
13.1 Global CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.2.2 Canada CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.2.3 Mexico CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.2 UK CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.3 Spain CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.4 Belgium CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.5 France CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.6 Italy CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.7 Denmark CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.8 Finland CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.9 Norway CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.10 Sweden CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.11 Poland CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.12 Russia CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.13 Turkey CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.2 Japan CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.3 India CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.4 South Korea CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.5 Pakistan CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.7 Indonesia CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.8 Thailand CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.9 Singapore CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.10 Malaysia CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.11 Philippines CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.12 Vietnam CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.5.2 Colombia CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.5.3 Chile CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.5.4 Argentina CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.5.5 Venezuela CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.5.6 Peru CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.5.8 Ecuador CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.6.2 Kuwait CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.6.3 Oman CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.6.4 Qatar CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.7.2 South Africa CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.7.3 Egypt CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.7.4 Algeria CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
13.8.2 New Zealand CAR T-Cell Therapy Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of CAR T-Cell Therapy
-
Figure of CAR T-Cell Therapy Picture
-
Table Global CAR T-Cell Therapy Import by Region (Top 10 Countries) (2017-2028)
-
Table Global CAR T-Cell Therapy Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Allogeneic Consumption and Growth Rate (2017-2022)
-
Figure Global Autologous Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Research Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global CAR T-Cell Therapy Consumption by Country (2017-2022)
-
Table North America CAR T-Cell Therapy Consumption by Country (2017-2022)
-
Figure United States CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Canada CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Mexico CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe CAR T-Cell Therapy Consumption by Country (2017-2022)
-
Figure Germany CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure UK CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Spain CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Belgium CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure France CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Italy CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Denmark CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Finland CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Norway CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Sweden CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Poland CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Russia CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Turkey CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table APAC CAR T-Cell Therapy Consumption by Country (2017-2022)
-
Figure China CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure India CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Pakistan CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Indonesia CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Thailand CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Singapore CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Malaysia CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Philippines CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Vietnam CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table South America CAR T-Cell Therapy Consumption by Country (2017-2022)
-
Figure Brazil CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Colombia CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Chile CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Argentina CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Venezuela CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Peru CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Ecuador CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table GCC CAR T-Cell Therapy Consumption by Country (2017-2022)
-
Figure Bahrain CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Kuwait CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Oman CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Qatar CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Africa CAR T-Cell Therapy Consumption by Country (2017-2022)
-
Figure Nigeria CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Africa CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Egypt CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Algeria CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Oceania CAR T-Cell Therapy Consumption by Country (2017-2022)
-
Figure Australia CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure New Zealand CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table CARsgen Therapeutics (China) Company Details
-
Table CARsgen Therapeutics (China) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table CARsgen Therapeutics (China) CAR T-Cell Therapy Main Business and Markets Served
-
Table CARsgen Therapeutics (China) CAR T-Cell Therapy Product Portfolio
-
Table Sorrento Therapeutics (US) Company Details
-
Table Sorrento Therapeutics (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sorrento Therapeutics (US) CAR T-Cell Therapy Main Business and Markets Served
-
Table Sorrento Therapeutics (US) CAR T-Cell Therapy Product Portfolio
-
Table Kite Pharma (US) Company Details
-
Table Kite Pharma (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kite Pharma (US) CAR T-Cell Therapy Main Business and Markets Served
-
Table Kite Pharma (US) CAR T-Cell Therapy Product Portfolio
-
Table Legend Biotech (US) Company Details
-
Table Legend Biotech (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Legend Biotech (US) CAR T-Cell Therapy Main Business and Markets Served
-
Table Legend Biotech (US) CAR T-Cell Therapy Product Portfolio
-
Table Pfizer, Inc (US) Company Details
-
Table Pfizer, Inc (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer, Inc (US) CAR T-Cell Therapy Main Business and Markets Served
-
Table Pfizer, Inc (US) CAR T-Cell Therapy Product Portfolio
-
Table Mustang Bio (US) Company Details
-
Table Mustang Bio (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mustang Bio (US) CAR T-Cell Therapy Main Business and Markets Served
-
Table Mustang Bio (US) CAR T-Cell Therapy Product Portfolio
-
Table Juno Therapeutics (US) Company Details
-
Table Juno Therapeutics (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Juno Therapeutics (US) CAR T-Cell Therapy Main Business and Markets Served
-
Table Juno Therapeutics (US) CAR T-Cell Therapy Product Portfolio
-
Table Novartis AG (Switzerland) Company Details
-
Table Novartis AG (Switzerland) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG (Switzerland) CAR T-Cell Therapy Main Business and Markets Served
-
Table Novartis AG (Switzerland) CAR T-Cell Therapy Product Portfolio
-
Table Cellectis (France) Company Details
-
Table Cellectis (France) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cellectis (France) CAR T-Cell Therapy Main Business and Markets Served
-
Table Cellectis (France) CAR T-Cell Therapy Product Portfolio
-
Table Autolus Therapeutics PLC (UK) Company Details
-
Table Autolus Therapeutics PLC (UK) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Autolus Therapeutics PLC (UK) CAR T-Cell Therapy Main Business and Markets Served
-
Table Autolus Therapeutics PLC (UK) CAR T-Cell Therapy Product Portfolio
-
Figure Global Allogeneic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autologous Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CAR T-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Table North America CAR T-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe CAR T-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Germany CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure France CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC CAR T-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure China CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table South America CAR T-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Brazil CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC CAR T-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Bahrain CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa CAR T-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Nigeria CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania CAR T-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Australia CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
